Moderna's RSV shot wins FDA approval for use in older adults | Region

Moderna Inc. gained U.S. approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,New York ,United States , ,Pfizer ,Pfizer Inc ,Moderna Inc ,Drug Administration ,Tribune Content Agency ,Us Centers For Disease ,Massachusetts Based Moderna ,Bloomberg Intelligence ,Disease Control ,